A global champion for economic growth in Abu Dhabi Read more about Mubadala Investment Company

Imperial College London Diabetes Centre (ICLDC)

Imperial College London Diabetes Centre (ICLDC)

A one-stop, state-of-the-art, out-patient facility that specialises in diabetes treatment, research, training and public health awareness

Imperial College London Diabetes Centre (ICLDC)

Imperial College London Diabetes Centre has two centres – one in Abu Dhabi and another in Al Ain.

The purpose-built centres, operated in partnership with the UK’s Imperial College London, provide the highest level of specialized patient care, from first diagnosis to the management of all complications associated with diabetes, and has offered diabetes prevention, education and treatment to more than 160,000 people.

Imperial College London Diabetes Centre holds the Joint Commission International (JCI) Clinical Care Program Certification (CCPC) in Diabetes Management and JCI Accreditation for Ambulatory Care; it is the first facility in the Middle East and the third globally to hold JCI’s highly-acclaimed CCPC for the clinical management of diabetes.

Imperial College London Diabetes Centre is a wholly owned subsidiary of Mubadala Development Company.

Other Healthcare Assets